EXPERIMENTAL EVALUATION OF THE METHODS FOR <i>FRANCISELLA TULARENSIS </i>15 NIIEG BIOMASS CONCENTRATION TO BE USED IN MANUFACTURING OF LIVE TULAREMIA VACCINE

The possibility of applying sedimentation, centrifuge, and filtration techniques for concentration of F. tularensis 15 NIIEG suspensions obtained after submerged cultivation has been evaluated. It is established that realization of tangential ultrafiltration as part of technological process of live...

Full description

Saved in:
Bibliographic Details
Main Authors: D. N. Bibikov, O. A. Volokh, A. V. Komissarov, Yu. I. Samokhvalova, N. G. Avdeeva, A. K. Nikiforov
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:Разработка и регистрация лекарственных средств
Subjects:
Online Access:https://www.pharmjournal.ru/jour/article/view/418
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850047105522991104
author D. N. Bibikov
O. A. Volokh
A. V. Komissarov
Yu. I. Samokhvalova
N. G. Avdeeva
A. K. Nikiforov
author_facet D. N. Bibikov
O. A. Volokh
A. V. Komissarov
Yu. I. Samokhvalova
N. G. Avdeeva
A. K. Nikiforov
author_sort D. N. Bibikov
collection DOAJ
description The possibility of applying sedimentation, centrifuge, and filtration techniques for concentration of F. tularensis 15 NIIEG suspensions obtained after submerged cultivation has been evaluated. It is established that realization of tangential ultrafiltration as part of technological process of live tularemia vaccine production is of distinct advantage. Characteristics of Francisella tularensis 15 NIIEG concentrate stored under different temperature/time-dependent conditions have also been studies. It is demonstrated that it is practical to preserve them at 4 °C within ≤6 days.
format Article
id doaj-art-dac8b1b6fd684bb7b5ff610230129920
institution DOAJ
issn 2305-2066
2658-5049
language Russian
publishDate 2019-01-01
publisher LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
record_format Article
series Разработка и регистрация лекарственных средств
spelling doaj-art-dac8b1b6fd684bb7b5ff6102301299202025-08-20T02:54:18ZrusLLC Center of Pharmaceutical Analytics (LLC «CPHA»)Разработка и регистрация лекарственных средств2305-20662658-50492019-01-0102130133418EXPERIMENTAL EVALUATION OF THE METHODS FOR <i>FRANCISELLA TULARENSIS </i>15 NIIEG BIOMASS CONCENTRATION TO BE USED IN MANUFACTURING OF LIVE TULAREMIA VACCINED. N. Bibikov0O. A. Volokh1A. V. Komissarov2Yu. I. Samokhvalova3N. G. Avdeeva4A. K. Nikiforov5Federal Government Health Institution Russian Research Anti-Plague Institute «Microbe», Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human WelfareFederal Government Health Institution Russian Research Anti-Plague Institute «Microbe», Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human WelfareFederal Government Health Institution Russian Research Anti-Plague Institute «Microbe», Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human WelfareFederal Government Health Institution Russian Research Anti-Plague Institute «Microbe», Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human WelfareFederal Government Health Institution Russian Research Anti-Plague Institute «Microbe», Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human WelfareFederal Government Health Institution Russian Research Anti-Plague Institute «Microbe», Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare; Federal State Funded Educational Institution of Higher Postgraduate Education «N.I. Vavilov Saratov State Agrarian University», Ministry of Agriculture of the Russian FederationThe possibility of applying sedimentation, centrifuge, and filtration techniques for concentration of F. tularensis 15 NIIEG suspensions obtained after submerged cultivation has been evaluated. It is established that realization of tangential ultrafiltration as part of technological process of live tularemia vaccine production is of distinct advantage. Characteristics of Francisella tularensis 15 NIIEG concentrate stored under different temperature/time-dependent conditions have also been studies. It is demonstrated that it is practical to preserve them at 4 °C within ≤6 days.https://www.pharmjournal.ru/jour/article/view/418francisella tularensisconcentrationlive tularemia vaccine
spellingShingle D. N. Bibikov
O. A. Volokh
A. V. Komissarov
Yu. I. Samokhvalova
N. G. Avdeeva
A. K. Nikiforov
EXPERIMENTAL EVALUATION OF THE METHODS FOR <i>FRANCISELLA TULARENSIS </i>15 NIIEG BIOMASS CONCENTRATION TO BE USED IN MANUFACTURING OF LIVE TULAREMIA VACCINE
Разработка и регистрация лекарственных средств
francisella tularensis
concentration
live tularemia vaccine
title EXPERIMENTAL EVALUATION OF THE METHODS FOR <i>FRANCISELLA TULARENSIS </i>15 NIIEG BIOMASS CONCENTRATION TO BE USED IN MANUFACTURING OF LIVE TULAREMIA VACCINE
title_full EXPERIMENTAL EVALUATION OF THE METHODS FOR <i>FRANCISELLA TULARENSIS </i>15 NIIEG BIOMASS CONCENTRATION TO BE USED IN MANUFACTURING OF LIVE TULAREMIA VACCINE
title_fullStr EXPERIMENTAL EVALUATION OF THE METHODS FOR <i>FRANCISELLA TULARENSIS </i>15 NIIEG BIOMASS CONCENTRATION TO BE USED IN MANUFACTURING OF LIVE TULAREMIA VACCINE
title_full_unstemmed EXPERIMENTAL EVALUATION OF THE METHODS FOR <i>FRANCISELLA TULARENSIS </i>15 NIIEG BIOMASS CONCENTRATION TO BE USED IN MANUFACTURING OF LIVE TULAREMIA VACCINE
title_short EXPERIMENTAL EVALUATION OF THE METHODS FOR <i>FRANCISELLA TULARENSIS </i>15 NIIEG BIOMASS CONCENTRATION TO BE USED IN MANUFACTURING OF LIVE TULAREMIA VACCINE
title_sort experimental evaluation of the methods for i francisella tularensis i 15 niieg biomass concentration to be used in manufacturing of live tularemia vaccine
topic francisella tularensis
concentration
live tularemia vaccine
url https://www.pharmjournal.ru/jour/article/view/418
work_keys_str_mv AT dnbibikov experimentalevaluationofthemethodsforifrancisellatularensisi15niiegbiomassconcentrationtobeusedinmanufacturingoflivetularemiavaccine
AT oavolokh experimentalevaluationofthemethodsforifrancisellatularensisi15niiegbiomassconcentrationtobeusedinmanufacturingoflivetularemiavaccine
AT avkomissarov experimentalevaluationofthemethodsforifrancisellatularensisi15niiegbiomassconcentrationtobeusedinmanufacturingoflivetularemiavaccine
AT yuisamokhvalova experimentalevaluationofthemethodsforifrancisellatularensisi15niiegbiomassconcentrationtobeusedinmanufacturingoflivetularemiavaccine
AT ngavdeeva experimentalevaluationofthemethodsforifrancisellatularensisi15niiegbiomassconcentrationtobeusedinmanufacturingoflivetularemiavaccine
AT aknikiforov experimentalevaluationofthemethodsforifrancisellatularensisi15niiegbiomassconcentrationtobeusedinmanufacturingoflivetularemiavaccine